Sangamo Therapeutics ran out of cash. Eli Lilly and Astellas want the science it spent decades building.
You’d think the number of animators would grow accordingly, but it didn’t increase that much,” said Fukumiya Ayano, of Nippon ...
Co-director/screenwriter Kenna Harris spoke to IndieWire about making Pixar's latest franchise entry, what got left on the ...
The sector framed new media and computer art not as a market novelty but as part of a long history of artists engaging with ...
Discover how AI, automation, and next-generation DMTA workflows are accelerating drug discovery with expert insights from TTP ...
Juma Al Haj’s latest solo exhibition explores how moments of crisis are absorbed, processed and translated into artistic ...
Strongly interacting quantum particles are key to some of the most fascinating phenomena in modern physics—from magnetism and ...
A new invention from the Department of Energy's Pacific Northwest National Laboratory (PNNL) could soon help manufacturers ...
To unlock the next level of manufacturing—the one that is knocking on our door right now—we must learn to use process and ...
From SpaceX veterans to AI-driven factories, see how robotics and software are slashing aerospace build times from months to ...
Manufacturing transistors that combine silicon with transition metal dichalcogenides (TMDs) requires an extremely precise ...
A new study from the Wilmer Eye Institute at Johns Hopkins Medicine suggests that artificial intelligence may help address ...